← Feed

$ZNTL

2 theses
bullish 100%neutral 0%bearish 0%
Avg return (3m)
—
Win rate (3m)
— (0 resolved)
1d3d1w1m3m6m1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 9, 9:01 AM ET
$ZNTLr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish
u/Avish_Golakiya · 2d ago14 prior · awaiting results
“Held since August at $4.84 average, currently $3.99”

10 penny biotechs I'm watching and slowly adding for September 2026, and the one I got wrong in August.

Azenosertib shows ~35% ORR in Cyclin E1-positive platinum-resistant ovarian cancer and will present full DENALI overall survival data at ESMO Oct 23-27. The author held it at $4.84 in August and retains position despite 18% drawdown.

At post $4.03Now $4.030.0% since postedas of Sep 9, 9:01 AM ET
original post →
$ZNTLr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish
u/Avish_Golakiya · 35d ago14 prior · awaiting results

10 penny biotechs I'm watching for August 2026, and adding slowly

Zentalis Pharma is developing azenosertib (WEE1 inhibitor) in platinum-resistant ovarian cancer with October 2023 data readout. Options trading at ±106% implied move suggests the market expects significant volatility around the catalyst.

Now $4.03as of Sep 9, 9:01 AM ET
original post →

End of results.